Search Results - "CHIBOWSKA, M"

Refine Results
  1. 1
  2. 2

    Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): electrocardiographic substudy--three months follow-up by Paulisiński, R, Chibowska, M, Biłan, A, Ostrowski, S, Weglarz, J, Krasowska, D, Hanzlik, J

    “…The ESS-1 study was designed to evaluate the long-term effects of enalapril (10 mg per day) on the cardiopulmonary system of patients with systemic sclerosis…”
    Get more information
    Journal Article
  3. 3

    Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): ECG exercise testing--three months follow-up by Biłan, A, Chibowska, M, Palusiński, R, Witczak, A, Ostrowski, S, Makaruk, B, Weglarz, J, Hanzlik, J, Krasowska, D

    “…The ESS-1 study was designed to evaluate the long-term effects of the angiotensin-converting enzyme inhibitor (ACEI) enalapril (10 mg per day) on…”
    Get more information
    Journal Article
  4. 4

    Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment by Ostrowski, S, Chibowska, M, Biłan, A, Palusiński, R, Weglarz, J, Makaruk, B, Krasowska, D, Hanzlik, J

    “…The ESS-1 study is designed to evaluate the long-term effects of enalapril on cardiopulmonary system of patients with systemic sclerosis (SSc). During the one…”
    Get more information
    Journal Article
  5. 5

    Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): echocardiographic substudy--three months follow-up by Biłan, A, Chibowska, M, Makaruk, B, Palusiński, R, Weglarz, J, Ostrowski, S, Witczak, A, Hanzlik, J, Krasowska, D

    “…The ESS-1 study was designed to evaluate the long-term effects of the angiotensin converting enzyme inhibitor (ACEI) enalapril (10 mg per day) on the…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients by Chibowska, M, Krasowska, D, Weglarz, J

    Published in Medical science monitor (01-03-2001)
    “…In this study we investigated whether plasma level of IL-2 or sIL-2R shows the clinical disease status. Plasma levels of IL-2 and sIL-2R were measured by ELISA…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Changes in various apolipoprotein levels in psoriasis by Toruniowa, B, Chibowska, M, Pietrzak, A

    Published in Przegląd dermatologiczny (01-03-1990)
    “…In 104 patients with common psoriasis the patterns of apolipoproteins A and B were studied in serum depending on the course of the disease, extent of skin…”
    Get more information
    Journal Article
  15. 15

    Clinical, histopathologic, immunofluorescent and ultrastructural estimation of 2 cases of epidermolysis bullosa acquisita by Lecewicz-Toruń, B, Chibowska, M, Chibowski, D, Siezieniewska, Z

    “…Two cases of EBA were presented. Both patients with the symptoms of the disease were previously treated with nonsteroid antiinflammatory drugs. A considerable…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Progressive hemifacial atrophy: ten-year observation of a case by Urban, J, Toruniowa, B, Chibowska, M

    Published in Cutis (New York, N.Y.) (01-08-1996)
    “…The authors describe the case of a 14-year-old girl who experienced progressive hemifacial atrophy at the age of three-and-a-half years. The patient's early…”
    Get more information
    Journal Article
  19. 19

    Studies of the role of cellular immunity and angiogenetic changes in the pathogenesis of circumscribed scleroderma by Majewski, S, Błaszczyk, M, Chibowska, M, Rosińska-Borkowska, D, Kencka, D, Rudnicka, L, Marczak, M, Makieła, B, Skiendzielewska, A, Jabłońska, S

    Published in Przegląd dermatologiczny (01-07-1990)
    “…The studies were performed in 48 patients with morphea and included evaluation of 1) antinuclear antibodies 2) lymphocyte induced angiogenesis 3) natural…”
    Get more information
    Journal Article
  20. 20